Alpha Cognition Inc. Common Stock (ACOG) Stock Price

ACOGStock

$9.75+20.37%52W

Market Cap$212.33M

P/E—

PEG Ratio—

Div yield—

Beta8.69

ACOG Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)56.86%

Price vs S&P 500 (4W)12.88%

VGM Score62.47

Book Value / Share (Quarterly)$2.64

P/TBV (Annual)2.27x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-1.39

Price vs S&P 500 (YTD)38.04%

Gross Margin (TTM)84.42%

Net Profit Margin (TTM)-232.24%

EPS (TTM)$-1.34

10-Day Avg Trading Volume0.20M

EPS Excl Extra (TTM)$-1.34

EPS (Annual)$-1.17

ROI (Annual)-33.06%

Gross Margin (Annual)81.26%

Cash / Share (Quarterly)$2.49

Revenue Growth QoQ (YoY)20.66%

ROA (Last FY)-25.92%

EBITD / Share (TTM)$-1.41

Operating Margin (TTM)-250.06%

Cash Flow / Share (Annual)$-0.95

P/B Ratio3.35x

P/B Ratio (Quarterly)2.08x

Net Income / Employee (Annual)$-291,100

EV / Revenue (TTM)12.79x

Net Interest Coverage (TTM)-3.45x

ROA (TTM)-41.83%

EPS Incl Extra (Annual)$-1.17

Current Ratio (Annual)8.65x

Quick Ratio (Quarterly)10.67x

3-Month Avg Trading Volume0.07M

52-Week Price Return20.37%

Revenue / Employee (TTM)$152,500

Tangible BV / Share (Quarterly)$2.62

P/S Ratio (Annual)18.85x

Asset Turnover (Annual)0.13x

52-Week High$10.14

EPS Excl Extra (Annual)$-1.17

26-Week Price Return68.10%

Quick Ratio (Annual)7.70x

13-Week Price Return67.53%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)12.64x

Enterprise Value$138.45M

Asset Turnover (TTM)0.18x

Revenue / Employee (Annual)$143,900

Pretax Margin (Annual)-202.24%

Cash / Share (Annual)$3.04

3-Month Return Std Dev54.55%

Net Income / Employee (TTM)$-354,100

ROE (Last FY)-33.06%

EPS Basic Excl Extra (Annual)$-1.17

Receivables Turnover (TTM)5.41x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.34

ROI (TTM)-54.13%

P/S Ratio (TTM)17.80x

Revenue / Share (Annual)$0.58

Tangible BV / Share (Annual)$2.86

Price vs S&P 500 (52W)2.06%

Year-to-Date Return50.00%

5-Day Price Return13.70%

EPS Normalized (Annual)$-1.17

Net Profit Margin (Annual)-202.24%

Month-to-Date Return17.75%

EBITD / Share (Annual)$-1.28

Operating Margin (Annual)-221.72%

EPS Basic Excl Extra (TTM)$-1.34

P/TBV (Quarterly)2.09x

P/B Ratio (Annual)2.26x

Inventory Turnover (TTM)0.49x

Pretax Margin (TTM)-232.24%

Book Value / Share (Annual)$2.88

Price vs S&P 500 (13W)64.73%

Beta8.69x

Revenue / Share (TTM)$0.50

ROE (TTM)-54.13%

52-Week Low$4.50

vGradeD

gGradeB

mGradeA

vgmGradeB

ACOG Earnings Surprise History

Q2 25-0.65est. -0.46

Q3 25-0.30est. -0.43

Q4 25-0.31est. -0.35

Q1 26-0.32est. -0.40

Q2 26-0.40est. -0.39

ACOG Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

4.11

4.10

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
ACOGAlpha Cognition Inc. Common Stock	D	B	A	$9.75
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
TECHBio-Techne Corp.	D	C	B	$72.33
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
RGENRepligen Corp	D	C	A	$181.69
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23

About Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases, including Alzheimer's disease. The company markets ZUNVEYL, an oral tablet formulation, and is building a commercial team targeting the long-term care market with a focus on positioning ZUNVEYL against existing acetylcholinesterase inhibitor treatments. The company is also pursuing licensing partnerships to expand ZUNVEYL's indications and formulations.